BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38940324)

  • 21. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
    Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of specificity and sensitivity of IRT/IRT protocol in the cystic fibrosis newborn screening program: 6-year experience of three tertiary centers.
    Ramasli Gursoy T; Asfuroglu P; Sismanlar Eyuboglu T; Aslan AT; Yilmaz AI; Unal G; Kibar BS; Pekcan S; Hangul M; Kose M; Budakoglu II; Acican D
    Eur J Pediatr; 2023 Mar; 182(3):1067-1076. PubMed ID: 36565324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.
    Gregg RG; Simantel A; Farrell PM; Koscik R; Kosorok MR; Laxova A; Laessig R; Hoffman G; Hassemer D; Mischler EH; Splaingard M
    Pediatrics; 1997 Jun; 99(6):819-24. PubMed ID: 9164776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome.
    Gunnett MA; Baker E; Mims C; Self ST; Gutierrez HH; Guimbellot JS
    Front Pediatr; 2023; 11():1127659. PubMed ID: 36969284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a Custom Next-Generation Sequencing Assay for Cystic Fibrosis Newborn Screening.
    Sicko RJ; Stevens CF; Hughes EE; Leisner M; Ling H; Saavedra-Matiz CA; Caggana M; Kay DM
    Int J Neonatal Screen; 2021 Nov; 7(4):. PubMed ID: 34842611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.
    Baker MW; Atkins AE; Cordovado SK; Hendrix M; Earley MC; Farrell PM
    Genet Med; 2016 Mar; 18(3):231-8. PubMed ID: 25674778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why cystic fibrosis newborn screening programs have failed to meet original expectations… thus far.
    Farrell PM
    Mol Genet Metab; 2023; 140(1-2):107679. PubMed ID: 37573205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.
    Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C;
    Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10-year experience.
    Escudero-Ávila R; Delgado-Pecellín C; Moreno-Valera MJ; Carrasco-Hernández L; Quintana-Gallego ME; Delgado-Pecellín I
    Pediatr Pulmonol; 2023 Sep; 58(9):2464-2468. PubMed ID: 36196044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The need for vigilance: the case of a false-negative newborn screen for cystic fibrosis.
    Dunn CT; Skrypek MM; Powers AL; Laguna TA
    Pediatrics; 2011 Aug; 128(2):e446-9. PubMed ID: 21727111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refinement of newborn screening for cystic fibrosis with next generation sequencing.
    Rock MJ; Baker M; Antos N; Farrell PM
    Pediatr Pulmonol; 2023 Mar; 58(3):778-787. PubMed ID: 36416003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening.
    DeCelie-Germana JK; Bonitz L; Langfelder-Schwind E; Kier C; Diener BL; Berdella M
    Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis.
    Padoan R; Genoni S; Moretti E; Seia M; Giunta A; Corbetta C
    Acta Paediatr; 2002; 91(1):82-7. PubMed ID: 11883825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.
    Massie J; Curnow L; Tzanakos N; Francis I; Robertson CF
    Arch Dis Child; 2006 Mar; 91(3):222-5. PubMed ID: 16243854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening.
    McColley SA; Martiniano SL; Ren CL; Sontag MK; Rychlik K; Balmert L; Elbert A; Wu R; Farrell PM
    J Cyst Fibros; 2023 Jan; 22(1):89-97. PubMed ID: 35871976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Signatures of Cystic Fibrosis Identified in Dried Blood Spots For Newborn Screening Without Carrier Identification.
    DiBattista A; McIntosh N; Lamoureux M; Al-Dirbashi OY; Chakraborty P; Britz-McKibbin P
    J Proteome Res; 2019 Mar; 18(3):841-854. PubMed ID: 30507207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five years of experience with biochemical cystic fibrosis newborn screening based on IRT/PAP in Germany.
    Sommerburg O; Hammermann J; Lindner M; Stahl M; Muckenthaler M; Kohlmueller D; Happich M; Kulozik AE; Stopsack M; Gahr M; Hoffmann GF; Mall MA
    Pediatr Pulmonol; 2015 Jul; 50(7):655-64. PubMed ID: 25914230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
    Hughes EE; Stevens CF; Saavedra-Matiz CA; Tavakoli NP; Krein LM; Parker A; Zhang Z; Maloney B; Vogel B; DeCelie-Germana J; Kier C; Anbar RD; Berdella MN; Comber PG; Dozor AJ; Goetz DM; Guida L; Kattan M; Ting A; Voter KZ; ; van Roey P; Caggana M; Kay DM
    Hum Mutat; 2016 Feb; 37(2):201-8. PubMed ID: 26538069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons learned from 20 years of newborn screening for cystic fibrosis.
    Massie RJ; Curnow L; Glazner J; Armstrong DS; Francis I
    Med J Aust; 2012 Jan; 196(1):67-70. PubMed ID: 22256939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.